Status:
COMPLETED
Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant
Lead Sponsor:
State University of New York - Upstate Medical University
Conditions:
Breast Tumors
Eligibility:
FEMALE
18-70 years
Brief Summary
Magnetic Resonance Spectroscopy (MRS) is a novel imaging technique for noninvasive probing of biochemical properties of tissue. While MRS does not generate images of tumor per se it allows biochemical...
Detailed Description
Recent in vivo studies have reported successful use of 1H and 31P MRS in differentiating between benign and malignant tumors in breast tissue. These studies demonstrated an increase in the choline met...
Eligibility Criteria
Inclusion
- subjects should have well defined suspicious breast lesion and that will be biopsied
- subjects are to include; varied volunteers with different breast tissue with characteristics such as dense breasts, fibrocystic breasts, "small" breasted and "large" breasted women.
Exclusion
- Women of childbearing potential who are not practicing a medically accepted method of birth control should not participate
- Subjects that are pregnant, breast-feeding, should not be able to participate
- Subjects having any of the following metallic devices, will be ineligible to participate in the study: pacemaker, prosthesis, artificial heart valve, coronary artery stents, TENS (Transcutaneous electric nerve stimulator) or other neurological stimulation units and surgical clips.
Key Trial Info
Start Date :
November 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT00639171
Start Date
November 1 2005
End Date
August 1 2015
Last Update
December 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SUNY Upstate Medical University
Syracuse, New York, United States, 13210